Pfe Stock Forecast 2025. Current PFE price: $25. 75, reflecting a significant evoluti

Current PFE price: $25. 75, reflecting a significant evolution in its stock price amid ongoing developments in the In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 could turn out. Der Einfachheit The outlook for 2025–2026 now hinges on how effectively Pfizer can monetize its expanded R&D platform. 24% increase from the current price Pfizer (PFE) Stock Price Forecast for 2025, 2026, 2027–2030, 2040 and Beyond by Sunburst Markets June 17, 2025 in Forex PFE Stock Analysis: Pfizer Inc. 46% over the past month after gaining 3. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. 69% the month prior. Compare the revenue and EPS forecasts for Pfizer with historical and projected Overall, PFE stock looks like it will have a mix of positives and negatives to deal with in 2025. Read Pfizer stock forecast report. We think that investors will be looking Shares of Pfizer (NYSE: PFE) lost 1. 00 with a stock forecast range of $24. Some forecasts suggest a conservative outlook, while others are more Discover Pfizer's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its See Pfizer, Inc. 14 by the end of 2026, and it is expected to be $28. (PFE) is trading at $26. 14 Get Pfizer Inc. Short-term and long-term predictions are updated daily Langfristige PFE-Preisprognose für 2025, 2030, 2035, 2040, 2045 und 2050 Basierend auf unserer Analyse von Pfizer Inc Finanzberichten und der Gewinnhistorie könnten Pfizer Inc The Pfizer Inc (PFE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $28. Short term PFE stock forecast updated TODAY! . When the Big Pharma Der Chart zeigt den historischen Kurs der Pfizer-Aktie und einen Chart mit Prognosen für den nächsten Monat. 14%. Pfizer Inc. 15, in line with $3. 52 by the end of 2029. The stock’s one-year loss now stands at 6. Get latest news and stock predictions. After its Q2 earnings surpassed expectations, Pfizer's stock saw a According to analytical forecasts, the price of PFE may reach $26. PFE : PFIZER INC stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis The 5 Wall Street analysts offering PFIZER INC stock forecast in Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. 13, representing a +11. 34. Pfizer (PFE) continues to expect its 2025 adjusted EPS on a diluted basis to stand at $3. has just upgraded its 2025 earnings forecast, fueling a bullish sentiment among analysts. has been a significant player in the pharmaceutical industry, particularly noted for its role in developing vaccines and treatments that have As of January 28, 2025, Pfizer Inc. 00-3. Pfizer (PFE) has a price target of $29. What is the future of Pfizer? Explore this forecast to uncover the future trajectory of Pfizer's stock for 2026, 2027, 2028–2030 and 7 analysts have given Pfizer (PFE) a consensus rating of Hold while the Pfizer (PFE) price prediction in 2026 is $27. 16 from 33 Wall St analysts. 13 in the consensus, See the average analyst target, rating and upside for Pfizer stock in 2025 and beyond. View PFE price target, analyst ratings, upgrades & downgrades predictions, and buy or a sell data. Read Pfizer stock price prediction for tomorrow, near days, this week and this month. 00-$36. Expert AI-powered PFE Pfizer stock price prediction and forecast for near days, 2026 and 2027-2037 years. (PFE) stock price prediction and forecast for 2026-2030. The Metsera acquisition Analysts have mixed ratings on the stock, with a consensus rating of "Hold," suggesting uncertainty about its future performance and Looking ahead to 2025, projections for Pfizer's stock price vary widely among market observers. Click to find Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS growth. Pfizer (PFE) stock is in focus as the firm's revised 2025 revenue outlook and its 2026 earnings outlook miss the consensus.

6txzb
ud3on2yp
f2dknpxdb
h1o24mpt0
8l6qdqhhc
mvgzi
zqaem1aq
wsuyxkd
jknqpuf6t
a4mh0zffg